ESC Heart Failure

Article	Citations
Correlation between coronary calcification and cardiac structure in non‐dialysis patients with chronic kidney disease	73
Myocardial viability assessment during Impella support with 18‐fluorodesoxyglucose PET imaging	64
Left atrial reverse remodelling predicts prognosis in patients with acute decompensated heart failure	61
The chronic heart failure evolutions: Different fates and routes	58
Letter to editor regarding the article ‘Prediction of heart failure events based on physiologic sensor data’	57
Device‐therapy in chronic heart failure: Cardiac contractility modulation versus cardiac resynchronization therapy	56
Assessing congestion using estimated plasma volume status: Ready for prime time?	50
Prevalence and characteristics of upfront diuretic resistance in acute heart failure: The P‐Value‐AHF study	49
Acyl ghrelin increases cardiac output while preserving right ventricular‐pulmonary arterial coupling in heart failure	48
Meta‐analysis of cardiac magnetic resonance in prognosticating left ventricular function in peripartum cardiomyopathy	47
Outcomes of cardiac resynchronization therapy (CRT) in cardiac sarcoidosis patients with a range of ejection fractions	46
Prognostic value of hypoxaemic burden from overnight oximetry in heart failure with preserved ejection fraction	46
Reply to letter to the editor: ‘Evaluating imaging modalities for pulmonary congestion: Beyond chest X‐ray and LDCT’	46
Long‐term outcomes of electrical storm patients listed for urgent heart transplantation but not transplanted acutely	43
Comparison of incidence, prevalence and death of aortic stenosis and aortic insufficiency in a nationwide Korean study	42
Meta‐Analysis Global Group in Chronic Heart Failure score for the prediction of mortality in valvular heart disease	42
Electron microscopic findings predict clinical outcomes in patients with non‐ischaemic cardiomyopathy	42
CA‐125 variation in acute heart failure: a single‐centre analysis	41
Elevated blood bicarbonate levels and long‐term adverse outcomes in patients with chronic heart failure	39
Echocardiographic pressure–strain loop‐derived stroke work of the right ventricle: validation against the gold standard	38
Revascularization for controlling hypertension and improving cardiorenal failure in Leriche syndrome	37
Impact of SARS‐Cov‐2 infection in patients with hypertrophic cardiomyopathy: results of an international multicentre registry	37
Global longitudinal strain and outcome after endoscopic mitral valve repair	36
High platelet reactivity is a predictor of left ventricular remodelling in patients with acute myocardial infarction	36
Characteristics and management of very elderly patients with heart failure: a retrospective, population cohort study	35

Familial risk of dilated and hypertrophic cardiomyopathy: a national family study in Sweden	35
Impact of global warming on weight in patients with heart failure during the 2019 heatwave in France	34
Hypertrophic cardiomyopathy with heart failure and ST‐segment elevation of the lateral wall	34
	34
Dynamic risk stratification using Markov chain modelling in patients with chronic heart failure	34
Oral iron supplementation in patients with heart failure: a systematic review and meta‐analysis	34
Activating transcription factor 4 drives the progression of diabetic cardiac fibrosis	33
	33
Cabergoline treatment promotes myocardial recovery in peripartum cardiomyopathy	33
Berberine up‐regulates miR‐340‐5p to protect myocardial ischaemia/reperfusion from HMGB1‐mediated inflammatory injury	33
Hypotension on cardiopulmonary stress test predicts 90 day mortality after LVAD implantation in INTERMACS 3–6 patients	33
Diverging role of epicardial adipose tissue across the entire heart failure spectrum	32
Patients with cardiac amyloidosis are at a greater risk of mortality and hospital readmission after acute heart failure	32
	32
Early left ventricular unloading after extracorporeal membrane oxygenation: rationale and design of EARLY‐UNLOAD trial	32
Clinical course of patients with hypertrophic cardiomyopathy away from tertiary referral care	32
Cushing's syndrome presenting as non‐atherosclerotic myocardial infarction and heart failure	31
Lung diffusion capacity correlates with pre‐implant pulmonary hypertension and predicts outcome after LVAD implantation	31
Increased acylcarnitines in infant heart failure indicate fatty acid oxidation inhibition: towards therapeutic options?	30
Atrial fibrillation ablation in patients with arrhythmia‐induced cardiomyopathy: a prospective multicentre study	30
Serum angiotensin‐converting enzyme levels indicating early sarcoidosis diagnosis and immunosuppressive therapy efficacy	30
Cardiovascular health metrics and risk of heart failure in a Finnish population: a prospective cohort study	29
Global differences in acute heart failure treatment: analysis of the STRONG‐HF site feasibility questionnaire	29
Impact of age on characteristics, performance measures and outcomes of inpatients for heart failure in Beijing, China	29
Prevalence and impact of malnutrition on readmission among hospitalized patients with heart failure in China	29
Factors influencing left ventricular thrombus resolution and its significance on clinical outcomes	29
Danish phase II trial using adipose tissue derived mesenchymal stromal cells for patients with ischaemic heart failure	29
Issue Information	29
Impact of adherence to guideline‐directed therapy on risk of death in HF patients across an ejection fraction spectrum	29
Feasibility of physiological pacing rate in cardiac resynchronization therapy	28
Machine learning approach to stratify complex heterogeneity of chronic heart failure: A report from the CHART‐2 study	28
Outcomes with sacubitril/valsartan in outpatients with heart failure and reduced ejection fraction: The ARIADNE registry	27
	27
Use of sodium glucose co‐transporter 2 inhibitors in acute heart failure: a practical guidance	27
Oral milrinone for management of refractory right ventricular failure in patients with left ventricular assist devices	27
Incidence and impact of atrial fibrillation in heart failure patients: real‐world data in a large community	27
Rnf144b alleviates the inflammatory responses and cardiac dysfunction in sepsis	27
The use of MitraClip for nonobstructive hypertrophic cardiomyopathy with mixed severe mitral valve regurgitation	27
Integrated care for older multimorbid heart failure patients: protocol for the ESCAPE randomized trial and cohort study	27
Comparison of liver fibrosis scores for predicting mortality and morbidity in heart failure with preserved ejection fraction	27
Heart transplantation in patients bridged with mechanical circulatory support: outcome comparison with matched controls	27
Sex differences in natural history of cardiovascular magnetic resonance‐ and biopsy‐proven lymphocytic myocarditis	26
GDF‐15 at admission predicts cardiovascular death, heart failure, and bleeding outcomes in patients with CAD	26
Interleukin‐1 blockade in heart failure: an on‐treatment and off‐treatment cardiorespiratory fitness analysis	26
Predictive value of global longitudinal strain by left ventricular ejection fraction	26
Heart failure with preserved ejection fraction in haemodialysis patients: prevalence, diagnosis, risk factors, prognosis	26
Circulating microRNAs and cardiomyocyte proliferation in heart failure patients related to 10 years survival	26
Prognostic value of the NEWS + Lactate score in patients with decompensated heart failure in the emergency department	26
Angiotensin pathways under therapy with empagliflozin in patients with chronic heart failure	26
Impedance‐based remote monitoring in patients with heart failure and concomitant chronic kidney disease	26

Serum potassium level and mineralocorticoid receptor antagonist dose in a large cohort of chronic heart failure patients	26
Resistin and risks of incident heart failure subtypes and cardiac fibrosis: the Multi‐Ethnic Study of Atherosclerosis	25
Acylation‐stimulating protein and heart failure progression in arrhythmogenic right ventricular cardiomyopathy	25
Use of liver stiffness measurements in acute decompensated heart failure: new applications of a non‐invasive technique	25
Uncovering the genetic links of SARS‐CoV‐2 infections on heart failure co‐morbidity by a systems biology approach	25
Intestinal permeability evaluation in patients with chronic Chagas heart failure	25
HOXA cluster antisense RNA 2 elevates KIAA1522 expression through microRNA‐520d‐3p and insulin like growth factor 2 mRNA binding protein 3 to promote the growth of vascular smooth muscle cells in thor	25
Biomarker profiles in heart failure with preserved vs. reduced ejection fraction: results from the DIAST‐CHF study	25
Detection of transthyretin amyloid cardiomyopathy by automated data extraction from electronic health records	25
Prognostic significance of medical therapy in patients with heart failure with reduced ejection fraction	25
Pre‐operative risk factors for driveline infection in left ventricular‐assist device patients	25
Minimal subphenotyping model for acute heart failure with preserved ejection fraction	25
Vagus nerve stimulation‐induced stromal cell‐derived factor‐l alpha participates in angiogenesis and repair of infarcted hearts	25
Importance of the ‘area under the curve’ from serial NT‐proBNP measurements during treatment with sacubitril/valsartan	25
The predictive value of self‐compassion for psychological adjustment in left ventricular assist device patients: an observational study	24
Real‐time pulmonary artery pressure monitoring in heart failure patients: an updated cost‐effectiveness analysis	24
Clinically suspected lethal viral myocarditis combined with encephalitis: a COVID‐19 vaccine complication	24
New insight: particle flow rate from the airways as an indicator of cardiac failure in the intensive care unit	24
Cardiac involvement in patients recovering from Delta Variant of COVID‐19: a prospective multi‐parametric MRI study	24
Heart failure and trimethylamine N‐oxide: time to transform a ‘gut feeling’ in a fact?	24
Cardiovascular and metabolic determinants of quality of life in patients with cancer	24
Myocardial infarction with non‐obstructive disease and anomalous coronary origin: look for the common in the uncommon	24
Underdiagnosed Roifman syndrome manifested as non‐ischaemic cardiomyopathy: a case report	24
The development and initial validation of the PROMIS®+HF‐27 and PROMIS+HF‐10 profiles	24
The protective effect of LCZ696 in coxsackievirus B3‐induced acute viral myocarditis mice	24
Myocardial strain for heart failure with preserved ejection fraction but without diastolic dysfunction	24
Familial restrictive cardiomyopathy with novel missense variant of uncertain significance in the FLNC gene	23
Use of serial changes in biomarkers vs. baseline levels to predict left ventricular remodelling after STEMI	23
Lumican accumulates with fibrillar collagen in fibrosis in hypertrophic cardiomyopathy	23
Left atrial unloading with an 8 mm septal cutting balloon to treat postcapillary pulmonary hypertension: a case report	23
Serum microRNAs are key predictors of long‐term heart failure and cardiovascular death after myocardial infarction	23
Prediction of cardiac events with non‐contrast magnetic resonance feature tracking in patients with ischaemic cardiomyopathy	22
Daprodustat for anaemia in patients with heart failure and chronic kidney disease: A randomized controlled study	22
Identifying patients at increased risk for poor outcomes from heart failure with reduced ejection fraction: the PROMPT‐HF risk model	22
Usefulness of ventilatory inefficiency in predicting prognosis across the heart failure spectrum	22
An altered plasma lipidome–phenome network characterizes heart failure with preserved ejection fraction	22
Discordance between aPTT and anti‐Xa in monitoring heparin anticoagulation in mechanical circulatory support	22
The prognostic value of heart rate at discharge in acute decompensation of heart failure with reduced ejection fraction	22
Asymptomatic COVID‐19 and ST‐elevation myocardial infarction in young adults: lessons learned from two similar cases	22
Echocardiographic and clinical predictors of cardiac amyloidosis: limitations of apical sparing	22
	22
Transcatheter aortic valve replacement in aortic stenosis and cardiac amyloidosis: a systematic review and meta‐analysis	21
Awareness, access, and adoption of natriuretic peptides for diagnosis of heart failure	21
Calcium channel blockers and clinical outcomes in patients with continuous‐flow left ventricular assist devices	21
European Society of Cardiology guidelines and 1 year outcomes of acute heart failure treatment in Central Asia and Europe	21
Ten‐year follow‐up of a case of eosinophilic granulomatous with polyangiitis	21
Analysis of the serum levels of RIP3 and Drp1 in patients with heart failure	21
Association of anaemia on heart failure and left ventricular function: A bidirectional Mendelian randomization study	21
Fibroblast growth factor 23 independently predicts adverse outcomes after an acute coronary syndrome	21
B‐cell maturation antigen chimeric antigen receptor‐T therapy alleviated heart failure in patients with multiple myeloma	21
Sacubitril/valsartan for cardioprotection in breast cancer (MAINSTREAM): design and rationale of the randomized trial	21
Association between red blood cell distribution width‐to‐albumin ratio and prognosis in non‐ischaemic heart failure	21
Predictive value of NT pro BNP for new‐onset atrial fibrillation in heart failure and preserved ejection fraction	21
Computed tomography or chest X‐ray to assess pulmonary congestion in dyspnoeic patients with acute heart failure	21
Weak grip strength predicts higher unplanned healthcare utilization among patients with heart failure	21
Antiretroviral therapy and HIV‐associated cardiovascular disease: a prospective cardiac biomarker and CMR tissue characterization study	20
Predicting 1 year readmission for heart failure: A comparative study of machine learning and the LACE index	20
Prediction of heart failure events based on physiologic sensor data in HINODE defibrillator patients	20
Can right ventricular endomyocardial biopsy predict left ventricular fibrosis beforehand in dilated cardiomyopathy?	20
Medicines optimization prior to discharge in patients admitted to hospital with heart failure	20
Sex differences in clinical characteristics and long‐term clinical outcomes in Asian hospitalized heart failure patients	20
Integration of two‐dimensional echocardiography: A novel risk indicator for ST‐segment elevation myocardial infarction	20
Transcatheter edge‐to‐edge repair in papillary muscle injury complicating acute myocardial infarction	20
Long‐term outcomes and reverse remodelling in recently diagnosed unexplained left ventricular systolic dysfunction	20
The correlation between albumin‐corrected anion gap and prognosis in patients with acute myocardial infarction	19
Cardiac magnetic resonance‐based layer‐specific strain in immune checkpoint inhibitor‐associated myocarditis	19
Impact of cannabidiol on myocardial recovery in patients with acute myocarditis: Rationale & design of the ARCHER trial	19
Anxiety disorder and cardiovascular disease: a two‐sample Mendelian randomization study	19
Taking a walk on the heart failure side: comparison of metabolic variables during walking and maximal exertion	19
Early achievement of walkability after cardiac surgery and the risk of cardiovascular disease after hospital discharge	19
Economic aspects of long‐term left ventricular assist device treatment for chronic heart failure	19
Development of a quality of life measure for left ventricular assist device recipients using a mixed methods approach	19
Effects of baroreflex activation therapy on cardiac function and morphology	19
Identification of a novel likely pathogenic TPM1 variant linked to hypertrophic cardiomyopathy in a family with sudden cardiac death	19
Predicting cardiovascular events with fluoropyrimidine chemotherapy using a standard cardiovascular risk calculator	18
Echocardiographic haemodynamic monitoring in the context of HeartMate 3™ therapy: a systematic review	18
Cardiac sympathetic nerve activity trends after renal denervation in heart failure with preserved ejection fraction	18
Adverse plasma branched‐chain amino acid profile mirrors fatty muscle degeneration in diabetic heart failure patients	18
Pro‐adrenomedullin as an independent predictive biomarker for heart failure in atrial fibrillation and flutter	18
Machine learning‐driven diagnostic signature provides new insights in clinical management of hypertrophic cardiomyopathy	18

Usefulness of oxygen uptake efficiency slope in a 6 min walk test in chronic heart failure	18
Multifactorial risk factors for hospital readmissions among patients with symptoms of advanced heart failure	18
Renal ultrasonography predicts worsening renal function in patients with heart failure under tolvaptan administration	18
Ca2+/calmodulin‐dependent kinase IIδC‐induced chronic heart failure does not depend on sarcoplasmic reticulum Ca2+ leak	18
Safety and efficacy of adaptive atrial pacing regulated by blood pressure during low‐level exercise: a proof‐of‐concept study	17
Association of lactate/albumin ratio with 3‐month readmission risk in heart failure patients: a retrospective study	17
Prognostic mortality factors in advanced light chain cardiac amyloidosis: A prospective cohort study	17
Systolic dysfunction and mortality in critically ill patients: more data are needed to believe in this association!	17
Corrigendum	17
Impact of bridging with left ventricular assist device on right ventricular function following heart transplantation	17
Comparison of feasibility and results of frailty assessment methods prior to left ventricular assist device implantation	17
Blood perfusion status is important in the prognosis of ventricular aneurysm complicated by ventricular septal rupture	17
Comparison of cardiovascular outcomes of new antihyperglycemic agents in Type 2 Diabetes Mellitus: a meta‐analysis	17
Haemodynamic implications of VA‐ECMO vs. VA‐ECMO plus Impella CP for cardiogenic shock in a large animal model	17
Synchronized diaphragmatic stimulation: a case report of a novel extra‐cardiac intervention for chronic heart failure	17
Association of chronic heart failure with mortality in old intensive care patients suffering from Covid‐19	17
Characterization of heart failure patients with reverse left ventricular remodelling post‐angiotensin receptor blockers/neprilysin inhibitors therapy	17
Corrigendum	17
Loop diuretic down‐titration at discharge in patients hospitalized for acute heart failure	17
Issue Information	17
Guideline‐directed medical therapy assessment in heart failure patients undergoing percutaneous mitral valve repair	17
Editors' highlight picks from 2023 in ESC heart failure	17
Burden of hospitalizations in newly diagnosed heart failure patients in Poland: real world population based study in years 2013–2019	17
Clinical characteristics and frailty status in heart failure with preserved vs. reduced ejection fraction	17
Different activation of MAPKs and Akt/GSK3β after preload vs. afterload elevation	17
Corrigendum	17
Adherence to heart failure treatment in patients with peripartum cardiomyopathy	17
Circ_0001206 regulates miR‐665/CRKL axis to alleviate hypoxia/reoxygenation‐induced cardiomyocyte injury in myocardial infarction	16
Intermittent inotropic therapy with levosimendan vs. milrinone in advanced heart failure patients	16
Discordance between estimated and measured changes in plasma volume among patients with acute heart failure	16
Right atrial pressure represents cumulative cardiac burden in heart failure with preserved ejection fraction	16
Heart failure associated with imported malaria: a nationwide Danish cohort study	16
Effects of intravenous furosemide plus small‐volume hypertonic saline solutions on markers of heart failure	16
Cardiac allograft vasculopathy and donor age affecting permanent pacemaker implantation after heart transplantation	16
Incident heart failure and myocardial infarction in sodium‐glucose cotransporter‐2 vs. dipeptidyl peptidase‐4 inhibitor users	16
Functional classification of left ventricular remodelling: prognostic relevance in myocardial infarction	16
Acute and chronic exercise training in patients with Class II pulmonary hypertension: effects on haemodynamics and symptoms	16
Increase of serum pancreatic enzymes during hospitalization for acute heart failure	16
Bail‐out treatment of pulmonary embolism using a large‐bore aspiration mechanical thrombectomy device	16
The Shrunken pore syndrome is associated with poor prognosis and lower quality of life in heart failure patients: the HARVEST‐Malmö study	16
Association of adherence to a 3 month cardiac rehabilitation with long‐term clinical outcomes in heart failure patients	16
Genetic variation in sodium glucose co‐transporter 1 and cardiac structure and function at middle age	16
Up‐titration of medication in patients with new‐onset heart failure with and without atrial fibrillation	16
Corrigendum	16
Long‐term administration of intravenous inotropes in advanced heart failure	16
Sacubitril/valsartan improves cardiac function in Chinese patients with heart failure: a real‐world study	16
Identification of vital modules and genes associated with heart failure based on weighted gene coexpression network analysis	16
Association of anaemia and all‐cause mortality in patients with ischaemic heart failure varies by renal function status	15
	15
Right ventricular expression of NT‐proBNP adds predictive value to REVEAL score in patients with pulmonary arterial hypertension	15
Judgement of the multidisciplinary team is an important predictor of mortality after cardiac resynchronization therapy	15
Plasma amino acid profiling improves predictive accuracy of adverse events in patients with heart failure	15
With appreciation	15
Advanced isolated light chain amyloid cardiomyopathy with negative immunofixation and normal free light chain ratio	15
Prognostic value of lung ultrasound in patients hospitalized for heart disease irrespective of symptoms and ejection fraction	15
Effectiveness of motivational interviewing on health‐service use and mortality: a secondary outcome analysis of the MOTIVATE‐HF trial	15
Issue Information	15
Creating an impact, not an impression: ESC Heart Failure in its seventh year	15
Myocardial ultrastructure can augment genetic testing for sporadic dilated cardiomyopathy with initial heart failure	15
Exercise‐induced B‐lines in heart failure with preserved ejection fraction occur along with diastolic function worsening	15
Admission NT‐proBNP and outcomes in patients without history of heart failure hospitalized with COVID‐19	15
Urinary N‐terminal pro‐brain natriuretic peptide: prognostic value in patients with acute chest pain	15
Shear wave elastography to evaluate hepatic damage in heart failure	15
Inhalation of publicly available indoor insecticide spray caused myocardial infarction type II: a case report	15
A case series of cardiac amyloidosis patients supported by continuous‐flow left ventricular assist device	15
Burst steroid therapy and quality of life in patients with acute heart failure: Insights from the CORTAHF trial	15
Extended follow‐up after wearable cardioverter‐defibrillator period: the PROLONG‐II study	15
Corrigendum	15
Correspondence with the editor about the article ‘Clinical implication of sarcopenia in patients with acute decompensated heart failure: Design and rationale’	14
Biomarker changes as surrogate endpoints in early‐phase trials in heart failure with reduced ejection fraction	14
Sudden cardiac death after acute decompensation in heart failure patients: implications of discharge haemoglobin levels	14
Prevalence and prognostic impact of left ventricular systolic dysfunction or pulmonary congestion after acute myocardial infarction	14
The effect of immunosuppressive therapy on cardiac involvements in anti‐mitochondrial antibody‐positive myositis	14
Neutrophils pro‐inflammatory and anti‐inflammatory cytokine release in patients with heart failure and reduced ejection fraction	14
Do differences among heart failure patients affect their access to treatment?	14
Delayed cardiac consequences unveiled by magnetic resonance imaging in a high‐voltage electric shock survivor	14
Disparities in clinical features and outcomes of peripartum cardiomyopathy in high versus low prevalent regions in Nigeria	14
Real‐world outcomes in cardiac resynchronization therapy patients: Primary results of the SMART registry	14
Models of cardiovascular surgery biobanking to facilitate translational research and precision medicine	14
Optimizing exercise testing‐based risk stratification to predict poor prognosis after acute heart failure	14
Real‐world eligibility for vericiguat in decompensated heart failure with reduced ejection fraction	14
Risk classification for long‐term mortality among patients with acute heart failure: China PEACE 4YMortality	14
Assessment of the impact of different N terminal pro brain natriuretic peptide thresholds on echocardiography services	14
Heart failure and atrial fibrillation: tachycardia‐mediated acute decompensation	14
Natriuretic peptides and C‐reactive protein in in heart failure and malnutrition: a systematic review and meta‐analysis	14
Cardiac computed tomography‐derived myocardial tissue characterization after anthracycline treatment	14
The Critical Role of Comorbidities in Managing Heart Failure with Preserved Ejection Fraction (HFpEF)	14
Impact of heart failure on all‐cause mortality in COVID‐19: findings from the Eurasian International Registry	14
Prognostic significance of growth differentiation factor‐15 across age in chronic heart failure	14
Clinical profile, associated events and safety of vericiguat in a real‐world cohort: The VERITA study	14
In‐hospital changes in the red blood cell distribution width and mortality in critically ill patients with heart failure	14
Age‐related survival after alcohol septal ablation in hypertrophic obstructive cardiomyopathy	14
Survival after myocardial infarction according to left ventricular function and heart failure symptoms	14
Assessing the link of malnutrition with diabetes and mortality risk in heart failure patients	14
Rationale and design of the AMULET study: A new Model of telemedical care in patients with heart failure	14